Archive for the ‘Scientific Meetings & Publications’ Category

Want to Control Hypertension? Treating Obesity Helps

February 8, 2024 — This is not exactly startling news. But two new studies this week do offer a very clear confirmation of one of the important benefits that comes from treating obesity – unmistakably better control of hypertension. One reason this is important is the substantial amount of disinformation that circulates to suggest obesity is not a real […]

Rethinking the Dosing of Obesity Medicines with AMG 133

February 6, 2024 — We learned recently that questions about the need for ongoing dosing with obesity medicines raise discomforting thoughts. After all, obesity is a chronic disease, so we can’t dispute the need for continued daily or weekly doses with obesity medicines. Or can we? Amgen seems to think we can. Monthly Dosing? Induction and Maintenance? With a […]

Ultra-Processed Foods: Facts, Fiction, and Speculation

February 5, 2024 — The perils of ultra-processed foods received widespread coverage in recent months – thanks in no small part to the publication and promotion of TV presenter and doctor of virology Chris Van Tulleken’s book Ultra-Processed People. Ultra-processed foods, in short, are commercially manufactured food products that include ingredients you wouldn’t cook with at home. Some of this […]

Mindfulness, Setbacks, and Self-Compassion

February 4, 2024 — February is an excellent month to consider the virtue of self-compassion – both generally and also specifically for dealing with setbacks in the goals we might be pursuing for this new year. Why? Well, to begin with, we’ve survived January and as Roz Chast and many others remind us, it can be a long and […]

Motivational Interviewing Flunks a Test with Pediatricians

February 2, 2024 — Motivational interviewing is a respected tool for helping people who are seeking care for obesity. It’s  all about listening  to and supporting a person’s motivations wanting medical obesity care. But yet again, we are learning that motivation is not the magic answer for overcoming obesity. This time, in Pediatrics, Ken Resnicow and colleagues have published […]

Who Gets and Fills Prescriptions for Obesity Medicines?

January 31, 2024 — Obesity is the most prevalent chronic disease in America, so you might think that prescriptions for obesity medicines are relatively common – but only if you are unfamiliar with prevailing attitudes about these medicines. Because in fact, even in a large health system known for excellent care in cardiometabolic health, these prescriptions are rather rare. […]

Weight Regain in the Real World vs a Placebo-Controlled Trial

January 30, 2024 — It created quite a stir last week when Epic Research published an analysis suggesting that weight regain in the real world does not look the same as a placebo-controlled trial. After all, regain is quite an important subject. Obesity is clearly a chronic disease, requiring chronic care. But lots of people try to avoid this […]

The Rise of Contempt Above Curiosity and Reason

January 28, 2024 — In public life and unfortunately, in science and health policy, we find too often that contempt takes over from curiosity and reason. It is obvious in politics and likely to get painful this year. But it is not confined to the political realm. In nutrition and obesity research, we find that people are often ready […]

The Overselling of Diet and Exercise for Diabetes Remission

January 27, 2024 — Zeal is thrilling. “The solution is at hand” for type 2 diabetes, says Professor Roy Taylor. “If a person has T2DM, they have become too heavy for their own body.” Losing weight with his very low calorie diet will put that diabetes into remission, he says. “A simple bottom line.” Except that a new study […]

More Calls for People with Obesity in Drug Trials and Labels

January 26, 2024 — The calls are growing louder and more frequent to include people living with obesity in clinical trials and drug labels. Of course trials and labels for drugs that treat obesity include these patients. But the huge problem is that for everything else, more often than not, drug studies and labels exclude them. Now, the American […]